三环类和四环类抗抑郁药的心血管作用。
Cardiovascular effects of tricyclic and tetracyclic antidepressants.
出版信息
Can Fam Physician. 1979 May;25:619-25.
Abstract
This article reviews all available studies on the cardiovascular effects of tri- and tetracyclic antidepressants at therapeutic and toxic levels. There is growing evidence that tricyclics, even at therapeutic levels, can be cardiotoxic. Plasma TCA levels are too variable to define a safe therapeutic range. Any patient showing cardiovascular side effects should have an ECG before continuing medication.
摘要
这篇文章综述了所有关于三环和四环抗抑郁药在治疗和中毒水平下对心血管影响的研究。越来越多的证据表明，三环类药物即使在治疗水平也可能具有心脏毒性。血浆 TCA 水平变化太大，无法定义安全的治疗范围。任何出现心血管副作用的患者在继续用药前都应该进行心电图检查。
相似文献
1
Cardiovascular effects of tricyclic and tetracyclic antidepressants.三环类和四环类抗抑郁药的心血管作用。
Can Fam Physician. 1979 May;25:619-25.
2
Cardiovascular effects of tricyclic and tetracyclic antidepressants.
JAMA. 1978 Jan 16;239(3):213-6.
3
Comparative animal studies on cardiovascular toxicity of tri- and tetracyclic antidepressants and citalopram; relation to drug plasma levels.三环和四环抗抑郁药及西酞普兰心血管毒性的动物对比研究；与药物血浆水平的关系。
Psychopharmacology (Berl). 1984;82(4):275-81. doi: 10.1007/BF00427669.
4
Therapeutic implications of tricyclic antidepressant plasma levels.
J Nerv Ment Dis. 1976 Jun;162(6):430-6. doi: 10.1097/00005053-197606000-00009.
5
6
7
Cardiovascular effects of therapeutic doses of tricyclic antidepressants in children and adolescents.治疗剂量的三环类抗抑郁药对儿童和青少年的心血管影响。
J Am Acad Child Adolesc Psychiatry. 1996 Nov;35(11):1491-501. doi: 10.1097/00004583-199611000-00018.
8
Using tricyclic antidepressants in the elderly.
Clin Geriatr Med. 1992 May;8(2):323-34.
9
Plasma levels of tricyclic antidepressants and clinical efficacy: review of the literature -- part II.三环类抗抑郁药的血浆水平与临床疗效：文献综述——第二部分
J Clin Psychiatry. 1979 Feb;40(2):58-69.
10
Electrophysiological effects of antidepressants on mammalian hearts and crayfish giant axon.
J Cardiovasc Pharmacol. 1981 Jan-Feb;3(1):101-12. doi: 10.1097/00005344-198101000-00009.
引用本文的文献
1
Structure-activity relationship of pharmacophores and toxicophores: the need for clinical strategy.药效团和毒性团的构效关系：临床策略的需要。
Daru. 2024 Dec;32(2):781-800. doi: 10.1007/s40199-024-00525-y. Epub 2024 Jun 27.
本文引用的文献
1
Hypotension from drugs: incidence, peril, prevention.药物引起的低血压：发生率、风险、预防
Dis Nerv Syst. 1974 Feb;35(2):66-71.
2
Pharmacological studies with tofranil.多虑平的药理学研究。
Can Psychiatr Assoc J. 1959;4(Suppl):75-85. doi: 10.1177/070674375900401s07.
3
AMITRIPTYLINE POISONING.
Lancet. 1965 Sep 4;2(7410):496. doi: 10.1016/s0140-6736(65)91458-3.
4
IMIPRAMINE-INDUCED AURICULAR FIBRILLATION.
Am J Psychiatry. 1965 Aug;122:216-7. doi: 10.1176/ajp.122.2.216.
5
INHIBITION OF NORADRENALINE UPTAKE BY DRUGS.药物对去甲肾上腺素摄取的抑制作用。
J Pharm Pharmacol. 1965 Jan;17:62-4. doi: 10.1111/j.2042-7158.1965.tb07572.x.
6
SPECIES DIFFERENCES IN THE METABOLISM OF IMIPRAMINE AND DESMETHYLIMIPRAMINE (DMI).丙咪嗪和去甲丙咪嗪（DMI）代谢中的种属差异。
J Pharmacol Exp Ther. 1964 Jan;143:14-22.
7
8
Cardiac complications during treatment with imipramin (Tofranil).丙咪嗪（托弗尼尔）治疗期间的心脏并发症。
Acta Psychiatr Scand. 1961;36(3):427-42. doi: 10.1111/j.1600-0447.1961.tb01057.x.
9
Effects of imipramine on the peripheral autonomic system.丙咪嗪对周围自主神经系统的作用。
Arch Int Pharmacodyn Ther. 1960 Dec 31;129:273-89.
10
The hypotensive effect of imipramine hydrocloride in patients with cardiovascular disease.盐酸丙咪嗪对心血管疾病患者的降压作用。
Clin Pharmacol Ther. 1961 May-Jun;2:300-7. doi: 10.1002/cpt196123300.
Zotero 插件